Skip to content

Gain the Decision Advantage

Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.

Register Now
  • About Us
    • Who We Are
    • Leadership
    • Corporate Citizenship
    • Partners
    • Contact Us
  • Customer Login
  • LifeSphere
    • MultiVigilance

    • Advanced Intake

    • Literature Intelligence

    • ReporterX

    • Advanced Signals

    • Business Intelligence

    • Document Distribution

    • Advanced Compliance Docs

    • RIM

    • Product Compliance

    • Documents

    • Submissions

    • Labeling

    • Regulatory Analytics

    • Health Authority Interactions

    • Regulatory Intelligence

    • Medical Information

    • Reporter

    • Product Complaints

    • Quality Management System

    • Quality Documents

    • Safety
      • MultiVigilance
      • Advanced Intake
      • Literature Intelligence
      • Advanced Compliance Docs
      • Business Intelligence
      • Reporter
      • ArisGlobal Launches ReporterX
    • Regulatory
      • RIM
      • Product Compliance
      • Documents
      • Submissions
      • Labeling
      • Regulatory Analytics
      • Health Authority Interactions
      • Intelligence
    • Medical Affairs
      • Medical Information
      • Reporter
    • Quality
      • Quality Management System
      • Quality Documents
  • NavaX
    • NavaX for Safety
      • MedDRA Coding Agent
      • Distribution Agents
      • Signals Agents
      • ReporterX
      • Advanced Intake
      • Literature Intelligence
      • Advanced Signals
      • Translation
    • NavaX for Regulatory
      • Intelligence Agents
      • Health Authority Interactions
      • Regulatory Intelligence
    • NavaX Agents
      • MedDRA Coding Agent
      • Signals Agents
      • Distribution Agents
      • Intelligence Agents
  • XDI
  • SPORIFY
  • Resources
    • Webinars
    • Case Studies
    • Resources Library
    • Consulting
  • Who We Serve
    • Customers
    • Enterprise
    • Small to Medium Pharma
    • CROs
  • News
    • Breakthrough 2027
    • Events & Webinars
    • Media
    • Blogs & Articles
    • Podcasts
  • Book a Demo
  • LifeSphere
    • Safety
      • MultiVigilance
      • Advanced Intake
      • Literature Intelligence
      • Advanced Compliance Docs
      • Advanced Signals
      • Business Intelligence
      • Document Distribution
      • Reporter
      • Translation
    • Regulatory
      • RIM
      • Product Compliance
      • Documents
      • Submissions
      • Labeling
      • Regulatory Analytics
      • Health Authority Interactions
      • Regulatory Intelligence
    • Medical Affairs
      • Medical Information
      • Reporter
    • Quality
      • Quality Management System
      • Quality Document Management System
  • NavaX
    • NavaX for Safety
      • Advanced Intake
      • Advanced Signals
      • Literature Intelligence
    • NavaX for Regulatory
      • Health Authority Interactions
      • Regulatory Intelligence
    • NavaX Agents
  • XDI
  • SPORIFY
  • Resources
    • Resources Library
    • Consulting
  • Who We Serve
    • Customers
    • Enterprise
    • Small to Medium Pharma
    • CROs
  • News
    • Events & Webinars
    • Media
    • Blog
  • Book a Demo
  • About Us
    • Who We Are
    • Leadership
    • Corporate Citizenship
    • Contact Us
  • Customer login
  • LifeSphere
    • Safety
      • MultiVigilance
      • Advanced Intake
      • Literature Intelligence
      • Advanced Compliance Docs
      • Advanced Signals
      • Business Intelligence
      • Document Distribution
      • Reporter
      • Translation
    • Regulatory
      • RIM
      • Product Compliance
      • Documents
      • Submissions
      • Labeling
      • Regulatory Analytics
      • Health Authority Interactions
      • Regulatory Intelligence
    • Medical Affairs
      • Medical Information
      • Reporter
    • Quality
      • Quality Management System
      • Quality Document Management System
  • NavaX
    • NavaX for Safety
      • Advanced Intake
      • Advanced Signals
      • Literature Intelligence
    • NavaX for Regulatory
      • Health Authority Interactions
      • Regulatory Intelligence
    • NavaX Agents
  • XDI
  • SPORIFY
  • Resources
    • Resources Library
    • Consulting
  • Who We Serve
    • Customers
    • Enterprise
    • Small to Medium Pharma
    • CROs
  • News
    • Events & Webinars
    • Media
    • Blog
  • Book a Demo
  • About Us
    • Who We Are
    • Leadership
    • Corporate Citizenship
    • Contact Us
  • Customer login
Industry Report

Transforming Regulatory Operations with AI: Why Frost & Sullivan Recognized ArisGlobal as a Visionary Leader

As life sciences organizations navigate increasing regulatory complexity and new global data standards, they need more than traditional RIM systems. Frost & Sullivan's 2026 Frost Radar™ recognized ArisGlobal as a Visionary Leader, highlighting its LifeSphere Regulatory platform, structured data foundation, and NavaX AI capabilities that help teams streamline regulatory workflows, improve compliance, and accelerate execution. View the Frost & Sullivan report on ArisGlobal to see why ArisGlobal  achieved the top innovation score across all profiled regulatory technology vendors and how they help transform regulatory operations with the latest AI innovations.
View Now
LifeSphere® Technology is trusted by these industry leaders:
Astellas logo
Roche logo
Boehringer Ingelheim logo
Astra Zeneca logo
Client logo

Resources

Let's Talk

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Get started!

Transforming Regulatory Operations with AI: Why Frost & Sullivan Recognized ArisGlobal as a Visionary Leader
Mladen Prenc2026-09-09T13:02:01+00:00

Share This on LinkedIn

LinkedIn

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

  • Home
  • Schedule a Demo
  • Careers
  • Privacy Policy
  • AI Trust Center
  • POSH Policy
  • Speak Up!
  • Contact Us

Follow Us

© 2026 ArisGlobal – All Rights Reserved

Page load link
Font resize
Contrast
Accessibility by WAH